Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christian Blank

Showing results (21-30 of 89) with videos related to

Pageof 9
Sort By:
JAAD Case Reports|December 5, 2018
Remission of psoriasis during treatment with sorafenibMarloes S van Kester, Saskia A C Luelmo, Maarten H Vermeer, et al.
Journal of the American Society of Echocardiography : Official Publication of the American Society of Echocardiography|August 27, 2013
Comparability of Z-score equations of cardiac structures in hypoplastic left heart complexMartijn H T den Dekker, Martijn G Slieker, A Christian Blank, et al.
Journal of the American Society of Echocardiography : Official Publication of the American Society of Echocardiography|January 21, 2014
Authors' replyMatthias W Freund, Martijn H T den Dekker, A Christian Blank, et al.
Cancer Research|February 12, 2004
PD-L1/B7H-1 inhibits the effector phase of tumor rejection by T cell receptor (TCR) transgenic CD8+ T cellsChristian Blank, Ian Brown, Amy C Peterson, et al.
Journal of Hepatology|August 1, 2006
PD-L1 is induced in hepatocytes by viral infection and by interferon-alpha and -gamma and mediates T cell apoptosisMarcus Mühlbauer, Martin Fleck, Christian Schütz, et al.
The Annals of Thoracic Surgery|April 28, 2015
Midterm Follow-Up After Biventricular Repair of the Hypoplastic Left Heart ComplexJan Erik Freund, Martijn H T den Dekker, A Christian Blank, et al.
European Journal of Immunology|December 7, 2011
Reduced tumor-antigen density leads to PD-1/PD-L1-mediated impairment of partially exhausted CD8⁺ T cellsAndrew D Kaiser, Kerstin Schuster, Jules Gadiot, et al.
Cancer|April 28, 2011
Overall survival and PD-L1 expression in metastasized malignant melanomaJules Gadiot, Anna I Hooijkaas, Andrew D M Kaiser, et al.
Cancer Letters|November 28, 2018
Metabolic targeting synergizes with MAPK inhibition and delays drug resistance in melanomaChristina Brummer, Stephanie Faerber, Christina Bruss, et al.
Journal of the National Cancer Institute|June 19, 2026
Prognostic dynamics of pathological complete response and ctDNA clearance after neoadjuvant/perioperative immunotherapy in cancer: a reconstructed individual patient analysisYago Garitaonaindia, Sonja Witteveen, Edoardo Dionisio, et al.
Pageof 9

Showing results (21-30 of 89) with videos related to

Sort By:
Pageof 9
JAAD Case Reports|December 5, 2018
Remission of psoriasis during treatment with sorafenibMarloes S van Kester, Saskia A C Luelmo, Maarten H Vermeer, et al.
Journal of the American Society of Echocardiography : Official Publication of the American Society of Echocardiography|August 27, 2013
Comparability of Z-score equations of cardiac structures in hypoplastic left heart complexMartijn H T den Dekker, Martijn G Slieker, A Christian Blank, et al.
Journal of the American Society of Echocardiography : Official Publication of the American Society of Echocardiography|January 21, 2014
Authors' replyMatthias W Freund, Martijn H T den Dekker, A Christian Blank, et al.
Cancer Research|February 12, 2004
PD-L1/B7H-1 inhibits the effector phase of tumor rejection by T cell receptor (TCR) transgenic CD8+ T cellsChristian Blank, Ian Brown, Amy C Peterson, et al.
Journal of Hepatology|August 1, 2006
PD-L1 is induced in hepatocytes by viral infection and by interferon-alpha and -gamma and mediates T cell apoptosisMarcus Mühlbauer, Martin Fleck, Christian Schütz, et al.
The Annals of Thoracic Surgery|April 28, 2015
Midterm Follow-Up After Biventricular Repair of the Hypoplastic Left Heart ComplexJan Erik Freund, Martijn H T den Dekker, A Christian Blank, et al.
European Journal of Immunology|December 7, 2011
Reduced tumor-antigen density leads to PD-1/PD-L1-mediated impairment of partially exhausted CD8⁺ T cellsAndrew D Kaiser, Kerstin Schuster, Jules Gadiot, et al.
Cancer|April 28, 2011
Overall survival and PD-L1 expression in metastasized malignant melanomaJules Gadiot, Anna I Hooijkaas, Andrew D M Kaiser, et al.
Cancer Letters|November 28, 2018
Metabolic targeting synergizes with MAPK inhibition and delays drug resistance in melanomaChristina Brummer, Stephanie Faerber, Christina Bruss, et al.
Journal of the National Cancer Institute|June 19, 2026
Prognostic dynamics of pathological complete response and ctDNA clearance after neoadjuvant/perioperative immunotherapy in cancer: a reconstructed individual patient analysisYago Garitaonaindia, Sonja Witteveen, Edoardo Dionisio, et al.
Pageof 9